Back to discover
Disease

Chromothripsis

Emerging research
MeSHChromothripsis
2
Publications
1
Related conditions
2020
Latest publication
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this disease.

What's happening now

An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.

No activity recorded in this window. Try a wider timeframe.

Research activity

2 papers

Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.

Major themes6
  • Genomics2
  • Chromothripsis1
  • DNA Mutational Analysis1
  • Evolution, Molecular1
  • Mutation1
  • Whole Genome Sequencing1
Leading journals2
  • Nature1
  • Nature genetics1
Leading researchers8
  • Cortés-Ciriano I1
  • Gordenin D1
  • Jain D1
  • Jung YL1
  • Klimczak LJ1
  • Lee JJ1
  • Park PJ1
  • Pellman DS1
Affiliations (unnormalised)6
  • Broad Institute of MIT and Harvard1
  • Centre for Molecular Science Informatics1
  • Dana-Farber Cancer Institute1
  • Dana-Farber Cancer Institute and Harvard Medical School1
  • European Molecular Biology Laboratory1
  • Genome Integrity and Structural Biology Laboratory1

Related conditions

1 match

Diseases frequently studied alongside this one. Number shows shared papers.

Neoplasms2

Reference

Authoritative identity, definition & identifiers.

Defined in MeSH

Massive number of chromosomal rearrangements and shattering that occurs in cancer cells. The breakpoints are located within one chromosome or chromosome arm.

Identifiers
MeSHChromothripsis
References & data sources
  • Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
  • Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
  • Related entities are derived from literature co-mention (studied together) — associative, not causal.